Effects of acute versus post-acute systemic delivery of neural progenitor cells on neurological recovery and brain remodeling after focal cerebral ischemia in mice

Cell Death and Disease

Volumn 5, Issue 8, 2014, Pages

  Doeppner, T R ^a   Kaltwasser, B ^a   Teli, M K ^a,b   Bretschneider, E ^c,d   Bahr M ^d   Hermann, D M ^a  

^a UNIVERSITY OF ESSEN MEDICAL SCHOOL   (Germany)

^b NATIONAL INSTITUTE OF TECHNOLOGY CALICUT   (India)

^c KLINIKUM MINDEN   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOTRANSPLANTATION; ANIMAL; BLOOD BRAIN BARRIER; BRAIN; C57BL MOUSE; CELL DIFFERENTIATION; CONVALESCENCE; CYTOLOGY; DISEASE MODEL; MALE; METABOLISM; MORTALITY; MOTOR ACTIVITY; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; PATHOLOGY; PHYSIOLOGY; STROKE; TRANSPLANTATION;

ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; CELL DIFFERENTIATION; DISEASE MODELS, ANIMAL; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; NEURAL STEM CELLS; NEUROGENESIS; RECOVERY OF FUNCTION; STROKE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84906891676     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.359     Document Type: Article

References (44)

1. Leong WK, Henshall TL, Arthur A, Kremer KL, Lewis MD, Helps SC et al. Human adult dental pulp stem cells enhance poststroke functional recovery through non-neural replacement mechanisms. Stem Cells Transl Med 2012; 1: 177-187.
2. Bacigaluppi M, Pluchino S, Martino G, Kilic E, Hermann DM. Neural stem/precursor cells for the treatment of ischemic stroke. J Neurol Sci 2008; 265: 73-77.
3. Bliss TM, Andres RH, Steinberg GK. Optimizing the success of cell transplantation therapy for stroke. Neurobiol Dis 2010; 37: 275-283.
4. Doeppner TR, Ewert TA, Tonges L, Herz J, Zechariah A, Elali A et al. Transduction of neural precursor cells with TAT-heat shock protein 70 chaperone: therapeutic potential against ischemic stroke after intrastriatal and systemic transplantation. Stem cells 2012; 30: 1297-1310.
5. Zheng W, Honmou O, Miyata K, Harada K, Suzuki J, Liu H et al. Therapeutic benefits of human mesenchymal stem cells derived from bone marrow after global cerebral ischemia. Brain Res 2010; 1310: 8-16.
6. Banerjee S, Williamson DA, Habib N, Chataway J. The potential benefit of stem cell therapy after stroke: an update. Vasc Health Risk Manag 2012; 8: 569-580.
7. Schwarting S, Litwak S, Hao W, Bahr M, Weise J, Neumann H. Hematopoietic stem cells reduce postischemic inflammation and ameliorate ischemic brain injury. Stroke 2008; 39: 2867-2875.
8. Blum B, Benvenisty N. The tumorigenicity of human embryonic stem cells. Adv Cancer Res 2008; 100: 133-158.
9. Blum B, Benvenisty N. The tumorigenicity of diploid and aneuploid human pluripotent stem cells. Cell Cycle 2009; 8: 3822-3830.
10. Bonnamain V, Neveu I, Naveilhan P. Neural stem/progenitor cells as a promising candidate for regenerative therapy of the central nervous system. Front Cell Neurosci 2012; 6: 17.
11. Bacigaluppi M, Pluchino S, Peruzzotti Jametti L, Kilic E, Kilic U, Salani G et al. Delayed post-ischaemic neuroprotection following systemic neural stem cell transplantation involves multiple mechanisms. Brain 2009; 132(Pt 8): 2239-2251.
12. Darsalia V, Allison SJ, Cusulin C, Monni E, Kuzdas D, Kallur T et al. Cell number and timing of transplantation determine survival of human neural stem cell grafts in stroke-damaged rat brain. J Cereb Blood Flow Metab 2011; 31: 235-242.
13. Minnerup J, Kim JB, Schmidt A, Diederich K, Bauer H, Schilling M et al. Effects of neural progenitor cells on sensorimotor recovery and endogenous repair mechanisms after photothrombotic stroke. Stroke 2011; 42: 1757-1763.
14. Giusto E, Donega M, Cossetti C, Pluchino S. Neuro-immune interactions of neural stem cell transplants: from animal disease models to human trials. Exp Neurol 2013; e-pub ahead of print 16 March 2013; doi:10.1016/j.expneurol.2013. 03.009.
15. Dibajnia P, Morshead CM. Role of neural precursor cells in promoting repair following stroke. Acta Pharmacol Sin 2013; 34: 78-90.
16. Hicks A, Jolkkonen J. Challenges and possibilities of intravascular cell therapy in stroke. Acta Neurobiol Exp 2009; 69: 1-11.
17. Guzman R, Choi R, Gera A, De Los Angeles A, Andres RH, Steinberg GK. Intravascular cell replacement therapy for stroke. Neurosurg Focus 2008; 24: E15.
18. Shen CC, Lin CH, Yang YC, Chiao MT, Cheng WY, Ko JL. Intravenous implanted neural stem cells migrate to injury site, reduce infarct volume, and improve behavior after cerebral ischemia. Curr Neurovasc Res 2010; 7: 167-179.
19. Janowski M, Walczak P, Date I. Intravenous route of cell delivery for treatment of neurological disorders: a meta-analysis of preclinical results. Stem Cells Dev 2010; 19: 5-16.
20. Doeppner TR, Hermann DM. Mesenchymal stem cells in the treatment of ischemic stroke: progress and possibilities. Stem Cells Cloning 2010; 3: 157-163.
21. Scheibe F, Ladhoff J, Huck J, Grohmann M, Blazej K, Oersal A et al. Immune effects of mesenchymal stromal cells in experimental stroke. J Cereb Blood Flow Metab 2012; 32: 1578-1588.
22. Doeppner TR, El Aanbouri M, Dietz GP, Weise J, Schwarting S, Bahr M. Transplantation of TAT-Bcl-xL-transduced neural precursor cells: long-term neuroprotection after stroke. Neurobiol Dis 2010; 40: 265-276.
23. Yan T, Chopp M, Ye X, Liu Z, Zacharek A, Cui Y et al. Niaspan increases axonal remodeling after stroke in type 1 diabetes rats. Neurobiol Dis 2012; 46: 157-164.
24. Stroemer P, Patel S, Hope A, Oliveira C, Pollock K, Sinden J. The neural stem cell line CTX0E03 promotes behavioral recovery and endogenous neurogenesis after experimental stroke in a dose-dependent fashion. Neurorehabil Neural Repair 2009; 23: 895-909.
25. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab 2007; 27: 6-13.
26. Rosenblum S, Wang N, Smith TN, Pendharkar AV, Chua JY, Birk H et al. Timing of intraarterial neural stem cell transplantation after hypoxia-ischemia influences cell engraftment, survival, and differentiation. Stroke 2012; 43: 1624-1631.
27. Song M, Kim YJ, Kim YH, Roh J, Kim SU, Yoon BW. Effects of duplicate administration of human neural stem cell after focal cerebral ischemia in the rat. Int J Neurosci 2011; 121: 457-461.
28. Moriyama Y, Takagi N, Tanonaka K. Intravenous injection of neural progenitor cells improved depression-like behavior after cerebral ischemia. Transl Psychiatry 2011; 1: e29.
29. Hassani Z, O'Reilly J, Pearse Y, Stroemer P, Tang E, Sinden J et al. Human neural progenitor cell engraftment increases neurogenesis and microglial recruitment in the brain of rats with stroke. PLoS One 2012; 7: e50444.
30. Bliss T, Guzman R, Daadi M, Steinberg GK. Cell transplantation therapy for stroke. Stroke 2007; 38(2 Suppl): 817-826.
31. Dirnagl U, Iadecola C, Moskowitz MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-397.
32. Kokaia Z, Martino G, Schwartz M, Lindvall O. Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nat Neurosci 2012; 15: 1078-1087.
33. Martino G, Bacigaluppi M, Peruzzotti-Jametti L. Therapeutic stem cell plasticity orchestrates tissue plasticity. Brain 2011; 134(Pt 6): 1585-1587.
34. Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008; 8: 726-736.
35. Martino G, Pluchino S, Bonfanti L, Schwartz M. Brain regeneration in physiology and pathology: the immune signature driving therapeutic plasticity of neural stem cells. Physiol Rev 2011; 91: 1281-1304.
36. Pekna M, Pekny M, Nilsson M. Modulation of neural plasticity as a basis for stroke rehabilitation. Stroke 2012; 43: 2819-2828.
37. Liu Z, Li Y, Zhang X, Savant-Bhonsale S, Chopp M. Contralesional axonal remodeling of the corticospinal system in adult rats after stroke and bone marrow stromal cell treatment. Stroke 2008; 39: 2571-2577.
38. Kalladka D, Muir KW. Brain repair: cell therapy in stroke. Stem Cells Cloning 2014; 7: 31-44.
39. Doeppner TR, Mlynarczuk-Bialy I, Kuckelkorn U, Kaltwasser B, Herz J, Hasan MR et al. The novel proteasome inhibitor BSc2118 protects against cerebral ischaemia through HIF1A accumulation and enhanced angioneurogenesis. Brain 2012; 135(Pt 11): 3282-3297.
40. Doeppner TR, Bretschneider E, Doehring M, Segura I, Senturk A, Acker-Palmer A et al. Enhancement of endogenous neurogenesis in ephrin-B3 deficient mice after transient focal cerebral ischemia. Acta Neuropathol 2011; 122: 429-442.
41. Zhang L, Schallert T, Zhang ZG, Jiang Q, Arniego P, Li Q et al. A test for detecting longterm sensorimotor dysfunction in the mouse after focal cerebral ischemia. J Neurosci Methods 2002; 117: 207-214.
42. Herz J, Hagen SI, Bergmuller E, Sabellek P, Gothert JR, Buer J et al. Exacerbation of ischemic brain injury in hypercholesterolemic mice is associated with pronounced changes in peripheral and cerebral immune responses. Neurobiol Dis 2014; 62: 456-468.
43. Chu HX, Kim HA, Lee S, Moore JP, Chan CT, Vinh A et al. Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. J Cereb Blood Flow Metab 2014; 34: 450-459.
44. Chiba Y, Sasayama T, Miyake S, Koyama J, Kondoh T, Hosoda K et al. Anti-VEGF receptor antagonist (VGA1155) reduces infarction in rat permanent focal brain ischemia. Kobe J Med Sci 2008; 54: E136-E146.